SUBJECTS : Psychopharmacology | Neurology | Neuropsychology | Psychiatry | Pharmacolog
Neuropsychopharmacology Reports: 2023, vol: , issue:
- 1)- Yohei Ohtani, Fumihiko Ueno, Mitsuru Kimura, Sachio Matsushita, Masaru Mimura, Hiroyuki Uchida. Highly endorsed screening and assessment scales for alcohol problems: A systematic review. Neuropsychopharmacology reports. 2023, 43 (4): 470-481
Cited : 1Read More - 2)- Deanna Malone, Blair N Costin, Dawn MacElroy, Mashael Al-Hegelan, Julie Thompson, Yuriy Bronshteyn. Phenobarbital versus benzodiazepines in alcohol withdrawal syndrome. Neuropsychopharmacology reports. 2023, 43 (4): 532-541Cited : 5Read More
- 3)- Mari Fukuda, Mohammad Chowdhury, Tanvir Turin Chowdhury, Hideki Tsumura, Rina Tsuchie, Minako Kinuta, Takashi Hisamatsu, Hideyuki Kanda. At-risk internet addiction and related factors among senior high school teachers in Japan based on a Nationwide survey. Neuropsychopharmacology reports. 2023, 43 (4): 553-560Cited : 0Read More
- 4)- Naotaka Izuo, Hajime Miyanishi, Daisuke Nishizawa, Takuma Fujii, Junko Hasegawa, Naomi Sato, Fumihiko Tanioka, Haruhiko Sugimura, Kazutaka Ikeda, Atsumi Nitta. DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers. Neuropsychopharmacology reports. 2023, 43 (4): 570-575Cited : 0Read More
- 5)- Munenori Katayama, So Fujishiro, Kanna Sugiura, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto. Stigmatized attitudes of medical staff toward people who use drugs and their determinants in Japanese medical facilities specialized in addiction treatment. Neuropsychopharmacology reports. 2023, 43 (4): 576-586Cited : 0Read More
- 6)- Kazuhiro Kurihara, Ayano Shiroma, Munenaga Koda, Hotaka Shinzato, Yoshikazu Takaesu, Tsuyoshi Kondo. Age-related cognitive decline is accelerated in alcohol use disorder. Neuropsychopharmacology reports. 2023, 43 (4): 587-595Cited : 1Read More
- 7)- Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J Rucker, Mikael H Sodergren. UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention-deficit/hyperactivity disorder. Neuropsychopharmacology reports. 2023, 43 (4): 596-606Cited : 2Read More
- 8)- Hu-Ming Chang, Ming-Chyi Huang, Su-Chen Fang, Shih-Ku Lin. Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment. Neuropsychopharmacology reports. 2023, 43 (4): 607-615Cited : 0Read More
- 9)- Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W Weatherall, James J Rucker, Michael W Platt, Mikael H Sodergren. An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry. Neuropsychopharmacology reports. 2023, 43 (4): 616-632Cited : 2Read More
- 10)- Kazuhiro Kurihara, Hotaka Shinzato, Yoshikazu Takaesu, Tsuyoshi Kondo. Associations between relapse and drinking behaviors in patients with alcohol use disorders: A 6-month prospective study. Neuropsychopharmacology reports. 2023, 43 (4): 633-640Cited : 1Read More
- 11)- Olena Zhabenko, Igor V Linskiy, Oleksandr I Minko, Valeriy N Kuzminov, Meike Gmeinwieser, Lars P Kiefer, Deirdre A Conroy. A qualitative assessment of insomnia in recovering alcohol-dependent patients. Neuropsychopharmacology reports. 2023, 43 (4): 641-646Cited : 0Read More
- 12)- Kensuke Miyazaki, Michiko Uchiyama. An adolescent boy with kleptomania and attention-deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report. Neuropsychopharmacology reports. 2023, 43 (4): 650-653Cited : 0Read More
- 13)- Satoshi Asakura, Naoki Yoshinaga, Hisashi Yamada, Yutaka Fujii, Nobuyuki Mitsui, Yoshihiro Kanai, Takeshi Inoue, Eiji Shimizu. Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021). Neuropsychopharmacology reports. 2023, 43 (3): 288-309Cited : 5Read More
- 14)- Yoshitaka Kawashima, Misa Yamada, Hiroki Furuie, Hiroshi Kuniishi, Kie Akagi, Tomoko Kawashima, Takamasa Noda, Mitsuhiko Yamada. Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review. Neuropsychopharmacology reports. 2023, 43 (3): 320-327Cited : 1Read More
- 15)- Yoshie Sakai, Satsuki Ito, Junya Matsumoto, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Naomi Hasegawa, Keiichiro Ishimaru, Kenichiro Miura, Ryota Hashimoto. Longitudinal characteristics of insight and clinical factors in patients with schizophrenia. Neuropsychopharmacology reports. 2023, 43 (3): 373-381Cited : 0Read More
- 16)- Golsa Khalatbari Mohseni, Seyed Ahmad Hosseini, Nastaran Majdinasab, Bahman Cheraghian. Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis. Neuropsychopharmacology reports. 2023, 43 (3): 382-390Cited : 6Read More
- 17)- Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, Hiroyoshi Takeuchi, Kazuo Mishima, Ken Inada. Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia. Neuropsychopharmacology reports. 2023, 43 (3): 391-402Cited : 0Read More
- 18)- Wataru Arihisa, Takeshi Kondo, Katsushi Yamaguchi, Junya Matsumoto, Hiroki Nakanishi, Yasuto Kunii, Hiroyasu Akatsu, Mizuki Hino, Yoshio Hashizume, Shumpei Sato, Shinji Sato, Shin-Ichi Niwa, Hirooki Yabe, Takehiko Sasaki, Shuji Shigenobu, Mitsutoshi Setou. Lipid-correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia. Neuropsychopharmacology reports. 2023, 43 (3): 403-413Cited : 1Read More
- 19)- Anna Kono, Yu Shikano, Kenji F Tanaka, Katsunori Yamaura, Iku Tsutsui-Kimura. Inhibition of the dorsomedial striatal direct pathway is essential for the execution of action sequences. Neuropsychopharmacology reports. 2023, 43 (3): 414-424Cited : 0Read More
- 20)- Junichi Goto, Masahiro Shono, Yasuhisa Abe, Yasutaka Fujita, Keishi Ueda, Binchi Yoshida, Yoshihiro Nabeshima. Preventive effect of aripiprazole once monthly on rehospitalization for bipolar disorder: A multicenter 1-year retrospective mirror image study. Neuropsychopharmacology reports. 2023, 43 (3): 425-433Cited : 2Read More
- 21)- Dennis Bomansang Daliri, Agani Afaya, Timothy Tienbia Laari, Adiak Fredrick, Ama Gaynor Ankamah, Susana Annan, Nancy Abagye. Five-year trend of antipsychotic prescription practices in a district Hospital in Ghana: A retrospective study. Neuropsychopharmacology reports. 2023, 43 (3): 434-439Cited : 1Read More
- 22)- Taro Sasaki, Masataka Shinozaki, Aki Nemoto, Yukiko Nagao, Manabu Yasuda, Kazutaka Shimoda, Shiro Suda, Norio Yasui-Furukori. Effects of age on suicide attempts by medication in patients transferred to the emergency rooms of two advanced medical centers: A retrospective chart review of the DJ project. Neuropsychopharmacology reports. 2023, 43 (3): 453-456Cited : 0Read More
- 23)- Momoka Yamada, Norio Sugawara, Yasushi Kawamata, Norio Yasui-Furukori. Differences in self-reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia. Neuropsychopharmacology reports. 2023, 43 (3): 457-461Cited : 3Read More
- 24)- Taro Kishi, Kenji Sakuma, Masakazu Hatano, Yuki Matsuda, Satoru Esumi, Nobumi Miyake, Itaru Miura, Hikaru Hori, Masaki Kato, Nakao Iwata. Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta-analysis. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 25)- Kensaku Nomoto, Jitsu Tajima, Takefumi Kikusui, Kazutaka Mogi. Long-term monitoring of huddling behavior in mice using online image processing. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 26)- Yasushi Kawamata, Norio Sugawara, Taro Sasaki, Saaya Yokoyama, Hiroaki Okayasu, Masataka Shinozaki, Yoshitaka Takeuchi, Aoi Sato, Takaaki Ishikawa, Hazuki Komahashi-Sasaki, Kensuke Miyazaki, Takashi Fukasawa, Hanako Furukori, Norio Yasui-Furukori. Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20-year period: Retrospective cohort study. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 27)- Kengo Yonezawa, Hideaki Tani, Shinichiro Nakajima, Hiroyuki Uchida. Development of the Japanese version of the 30-item Mystical Experience Questionnaire. Neuropsychopharmacology reports. 2023, : Cited : 2Read More
- 28)- Neda Mahdavifar, Khadijeh Kalan Farmanfarma, Masoud Hiteh, Maryam Mohammadian, Ali Abbasian, Fatemeh Vafi Sani, Razieh Khosrorad, Hamid Salehiniya. COVID-19 pandemic and the prevalence of domestic violence against Iranian married women. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 29)- Keisuke Mori, Fumitoshi Kodaka, Arisa Yamamoto, Ryuichi Yamazaki, Junpei Ishii, Wataru Yamadera, Hisatsugu Miyata, Masahiro Shigeta. Characteristics of patients with anxiety disorder without selective serotonin reuptake inhibitor prescription over a two-year period of pharmacotherapy. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 30)- Chia-Chien Liu, Chen-Chia Lan, Ying-Sheue Chen. The use of sertraline to treat an adolescent of dystonia comorbid with major depressive disorder with psychotic features. Neuropsychopharmacology reports. 2023, : Cited : 1Read More
- 31)- Matthew Murphy, Simon Erridge, Carl Holvey, Ross Coomber, James J Rucker, Mikael H Sodergren. A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance. Neuropsychopharmacology reports. 2023, : Cited : 3Read More
- 32)- Mobina Zeinalabedini, Zahra Mousavi, Arezoo Amjadi, Mahsa Shapouri, Bahareh Aminnezhad Kavkani, Mohammad Masoumvand, Khadijeh Abbasi Mobarakeh, Maryam Gholamalizadeh, Neda Valisoltani, Saeideh Mohammadi, Sara Khoshdooz, Saeid Doaei, Akram Kooshki. Does dietary intake of caffeine have an effect on transient global amnesia? Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 33)- Masanori Shimamoto, Kanako Ishizuka, Kento Ohtani, Toshiya Inada, Maeri Yamamoto, Masako Tachibana, Hiroki Kimura, Yusuke Sakai, Kazuhiro Kobayashi, Norio Ozaki, Masashi Ikeda. Machine learning algorithm-based estimation model for the severity of depression assessed using Montgomery-Asberg depression rating scale. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 34)- Fereshteh Ghorat, Mahdi Sepidarkish, Farzaneh Saadattalab, Maedeh Rezghi, Shamim Shahrestani, Maryam Gholamalizadeh, Saeid Doaei. The clinical efficacy of Olibanum gum chewing in patients with Mild-to-Moderate Alzheimer disease: A randomized Parallel-Design controlled trial. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 35)- Kentaro Kawabe, Fumie Horiuchi, Yu Matsumoto, Saori Inoue, Maya Okazawa, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu-Ichi Ueno. Practical clinical guidelines and pharmacological treatment for attention-deficit hyperactivity disorder in Asia. Neuropsychopharmacology reports. 2023, : Cited : 1Read More
- 36)- Hisanobu Kaiya. Anxious-depressive attack and rejection sensitivity-Toward a new approach to treatment-resistant depression. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 37)- Hiroko Sugawara, Akitoshi Date, Satoshi Fuke, Yutaka Nakachi, Tadafumi Kato, Minoru Narita, Miki Bundo, Kazuya Iwamoto. Quantification of cytosine modifications in the aged mouse brain. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 38)- Fen Xue, Xin-Fu Wang, Fan-Ni Kong, Tian-Lu Yin, Yu-Hong Wang, Li-Da Shi, Xiao-Wen Liu, Hui-Jing Yu, Li-Jun Liu, Ping Zhu, Xiao-Xue Qi, Xue-Jing Xu, Hong-Pu Hu, Su-Xia Li. Effects of bilateral repetitive transcranial magnetic stimulation on prospective memory in patients with schizophrenia: A double-blind randomized controlled clinical trial. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 39)- Yuta Nagatsuka, Dan Nakamura, Marie Ota, Gosuke Arai, Yuriko Iwami, Hirohisa Suzuki, Akisa Tomita, Yoichi Hanawa, Wakaho Hayashi, Akira Iwanami. Gaze measurements during viewing human dialogue scenes in adults with ADHD: Preliminary findings. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 40)- Mariko Tada, Kenji Kirihara, Tatsuya Nagai, Shinsuke Koike, Tsuyoshi Araki, Kiyoto Kasai. Gamma-band harmonic responses for beta-band auditory steady-state response are intact in patients with early stage schizophrenia. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 41)- Shinji Sato, Koubun Imai. The efficacy of vortioxetine for the delusional disorder of cenesthopathy. Neuropsychopharmacology reports. 2023, : Cited : 1Read More
- 42)- Satoshi Deyama, Xiao-Yuan Li, Ronald S Duman. Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in mice. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 43)- Takao Kato, Nozomu Kotorii, Motohiro Ozone, Kenta Murotani, Hayato Ohshima, Hiroyuki Mori, Kenjirou Wasano, Hiroshi Hiejima, Mitsunari Habukawa, Naohisa Uchimura. Trends in the multiple prescriptions of hypnotic drugs in a university outpatient in Japan. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 44)- Yoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, Daisuke Matsui, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, Toshiyuki Shimizu, Yuji Murase, Yosuke Koshikawa, Masaki Kato, Toshihiko Kinoshita. Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data. Neuropsychopharmacology reports. 2023, : Cited : 1Read More
- 45)- Tzuyao Lo, Itaru Kushima, Hiroki Kimura, Branko Aleksic, Takashi Okada, Hidekazu Kato, Toshiya Inada, Yoshihiro Nawa, Youta Torii, Maeri Yamamoto, Ryo Kimura, Yasuko Funabiki, Hirotaka Kosaka, Shusuke Numata, Kiyoto Kasai, Tsukasa Sasaki, Shigeru Yokoyama, Toshio Munesue, Ryota Hashimoto, Yuka Yasuda, Michiko Fujimoto, Masahide Usami, Masanari Itokawa, Makoto Arai, Kazutaka Ohi, Toshiyuki Someya, Yuichiro Watanabe, Jun Egawa, Tsutomu Takahashi, Michio Suzuki, Hidenori Yamasue, Nakao Iwata, Masas. Association between copy number variations in parkin (PRKN) and schizophrenia and autism spectrum disorder: A case-control study. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 46)- Yutaro Okawa, Shinichi Iwasaki, Yasuhiko Deguchi, Yoko Nakamichi, Yuki Uesaka, Shohei Okura, Kunio Maekubo, Koki Inoue. Association of worker's mental health with changes in exercise time, going-out time, and screen time (TV time, internet time, and game time) before and after the COVID-19 pandemic: A cross-sectional study. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 47)- Yosuke Saga, Chih-Lin Chiang, Akihide Wakamatsu. A descriptive analysis of spontaneous reports of antipsychotic-induced tardive dyskinesia and other extrapyramidal symptoms in the Japanese Adverse Drug Event Report database. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 48)- Ayako Kawaminami, Daisuke Yamada, Toshinori Yoshioka, Azumi Hatakeyama, Moeno Nishida, Keita Kajino, Tsuyoshi Saitoh, Hiroshi Nagase, Akiyoshi Saitoh. The delta opioid receptor agonist KNT-127 relieves innate anxiety-like behavior in mice by suppressing transmission from the prelimbic cortex to basolateral amygdala. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
- 49)- Takuya Uematsu, Takashi Tomita, Ryo Obara, Takuya Gonai, Koshi Hattori, Takanori Aonuma, Kensuke Usui, Hiroaki Tanifuji, Fumiaki Ishizawa, Hiroshi Ishii, Eiji Suzuki. Reducing the use of psychotropics in a convalescent rehabilitation ward. Neuropsychopharmacology reports. 2023, : Cited : 1Read More
- 50)- Kyle Arsenault-Mehta, Mario Hochman-Bérard, Alexander Johnson, Dar'ya Semenova, Bea Nguyen, Jessie Willis, Natalia Mouravska, Ridha Joober, Naista Zhand. Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review. Neuropsychopharmacology reports. 2023, : Cited : 0Read More
